Significant role of ceramide pathway in experimental gastric ulcer formation in rats

Keita Uehara, Soichiro Miura, Tetsu Takeuchi, Takao Taki, Manabu Nakashita, Masayuki Adachi, Toshiaki Inamura, Toshiko Ogawa, Yasutada Akiba, Hidekazu Suzuki, Hiroshi Nagata, Hiromasa Ishii

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ceramides have emerged as key participants in the signaling pathway of cytokines and apoptosis. We previously revealed that phorbol 12-myristate 13-acetate (PMA) induced experimental ulcers in rat gastric mucosa. In this study, we investigated the role of ceramide in ulcer formation and its relation to the activation of transcription factors and apoptosis. PMA was subserosally injected to rat glandular stomach. Fumonisin B1 (FB1), an inhibitor of ceramide synthase, was administered together with the PMA. The time course of ceramide content was quantified using thin layer chromatography and the number of apoptotic cells was determined by immunohistochemistry. The activation of transcription factor nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) was evaluated using an electrophoretic mobility shift assay. The administration of FB1 attenuated PMA-induced gastric ulcer formation in a dose-dependent manner. Before the ulcers became obvious, the ceramide content (C18 and C24 ceramide) increased significantly in the gastric wall. The activation of NF-κB and AP-1 and an increase in the number of apoptotic cells were also observed. Both of these were significantly inhibited by the coad-ministration of FB1. However, NF-κB inhibitors attenuated gastric ulcer formation without affecting the ceramide content or the number of apoptotic cells. Ceramide formation in the stomach significantly contributes to PMA-induced tissue damage, possibly via the activation of transcription factors and an increase in apoptosis in the gastric mucosa. However, after the increase in ceramide levels, the NF-κB and apoptosis pathways may be separately involved in ulcer formation.

Original languageEnglish
Pages (from-to)232-239
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume305
Issue number1
DOIs
Publication statusPublished - 2003 Apr 1

Fingerprint

Ceramides
Stomach Ulcer
Acetates
Ulcer
Apoptosis
Stomach
Transcription Factors
Cell Count
Transcription Factor AP-1
Gastric Mucosa
Electrophoretic Mobility Shift Assay
Thin Layer Chromatography
Immunohistochemistry
phorbol-12-myristate
Cytokines

ASJC Scopus subject areas

  • Pharmacology

Cite this

Significant role of ceramide pathway in experimental gastric ulcer formation in rats. / Uehara, Keita; Miura, Soichiro; Takeuchi, Tetsu; Taki, Takao; Nakashita, Manabu; Adachi, Masayuki; Inamura, Toshiaki; Ogawa, Toshiko; Akiba, Yasutada; Suzuki, Hidekazu; Nagata, Hiroshi; Ishii, Hiromasa.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 305, No. 1, 01.04.2003, p. 232-239.

Research output: Contribution to journalArticle

Uehara, K, Miura, S, Takeuchi, T, Taki, T, Nakashita, M, Adachi, M, Inamura, T, Ogawa, T, Akiba, Y, Suzuki, H, Nagata, H & Ishii, H 2003, 'Significant role of ceramide pathway in experimental gastric ulcer formation in rats', Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 1, pp. 232-239. https://doi.org/10.1124/jpet.102.045195
Uehara, Keita ; Miura, Soichiro ; Takeuchi, Tetsu ; Taki, Takao ; Nakashita, Manabu ; Adachi, Masayuki ; Inamura, Toshiaki ; Ogawa, Toshiko ; Akiba, Yasutada ; Suzuki, Hidekazu ; Nagata, Hiroshi ; Ishii, Hiromasa. / Significant role of ceramide pathway in experimental gastric ulcer formation in rats. In: Journal of Pharmacology and Experimental Therapeutics. 2003 ; Vol. 305, No. 1. pp. 232-239.
@article{9df8dc356d034e418cdca800d7ac35a5,
title = "Significant role of ceramide pathway in experimental gastric ulcer formation in rats",
abstract = "Ceramides have emerged as key participants in the signaling pathway of cytokines and apoptosis. We previously revealed that phorbol 12-myristate 13-acetate (PMA) induced experimental ulcers in rat gastric mucosa. In this study, we investigated the role of ceramide in ulcer formation and its relation to the activation of transcription factors and apoptosis. PMA was subserosally injected to rat glandular stomach. Fumonisin B1 (FB1), an inhibitor of ceramide synthase, was administered together with the PMA. The time course of ceramide content was quantified using thin layer chromatography and the number of apoptotic cells was determined by immunohistochemistry. The activation of transcription factor nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) was evaluated using an electrophoretic mobility shift assay. The administration of FB1 attenuated PMA-induced gastric ulcer formation in a dose-dependent manner. Before the ulcers became obvious, the ceramide content (C18 and C24 ceramide) increased significantly in the gastric wall. The activation of NF-κB and AP-1 and an increase in the number of apoptotic cells were also observed. Both of these were significantly inhibited by the coad-ministration of FB1. However, NF-κB inhibitors attenuated gastric ulcer formation without affecting the ceramide content or the number of apoptotic cells. Ceramide formation in the stomach significantly contributes to PMA-induced tissue damage, possibly via the activation of transcription factors and an increase in apoptosis in the gastric mucosa. However, after the increase in ceramide levels, the NF-κB and apoptosis pathways may be separately involved in ulcer formation.",
author = "Keita Uehara and Soichiro Miura and Tetsu Takeuchi and Takao Taki and Manabu Nakashita and Masayuki Adachi and Toshiaki Inamura and Toshiko Ogawa and Yasutada Akiba and Hidekazu Suzuki and Hiroshi Nagata and Hiromasa Ishii",
year = "2003",
month = "4",
day = "1",
doi = "10.1124/jpet.102.045195",
language = "English",
volume = "305",
pages = "232--239",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Significant role of ceramide pathway in experimental gastric ulcer formation in rats

AU - Uehara, Keita

AU - Miura, Soichiro

AU - Takeuchi, Tetsu

AU - Taki, Takao

AU - Nakashita, Manabu

AU - Adachi, Masayuki

AU - Inamura, Toshiaki

AU - Ogawa, Toshiko

AU - Akiba, Yasutada

AU - Suzuki, Hidekazu

AU - Nagata, Hiroshi

AU - Ishii, Hiromasa

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Ceramides have emerged as key participants in the signaling pathway of cytokines and apoptosis. We previously revealed that phorbol 12-myristate 13-acetate (PMA) induced experimental ulcers in rat gastric mucosa. In this study, we investigated the role of ceramide in ulcer formation and its relation to the activation of transcription factors and apoptosis. PMA was subserosally injected to rat glandular stomach. Fumonisin B1 (FB1), an inhibitor of ceramide synthase, was administered together with the PMA. The time course of ceramide content was quantified using thin layer chromatography and the number of apoptotic cells was determined by immunohistochemistry. The activation of transcription factor nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) was evaluated using an electrophoretic mobility shift assay. The administration of FB1 attenuated PMA-induced gastric ulcer formation in a dose-dependent manner. Before the ulcers became obvious, the ceramide content (C18 and C24 ceramide) increased significantly in the gastric wall. The activation of NF-κB and AP-1 and an increase in the number of apoptotic cells were also observed. Both of these were significantly inhibited by the coad-ministration of FB1. However, NF-κB inhibitors attenuated gastric ulcer formation without affecting the ceramide content or the number of apoptotic cells. Ceramide formation in the stomach significantly contributes to PMA-induced tissue damage, possibly via the activation of transcription factors and an increase in apoptosis in the gastric mucosa. However, after the increase in ceramide levels, the NF-κB and apoptosis pathways may be separately involved in ulcer formation.

AB - Ceramides have emerged as key participants in the signaling pathway of cytokines and apoptosis. We previously revealed that phorbol 12-myristate 13-acetate (PMA) induced experimental ulcers in rat gastric mucosa. In this study, we investigated the role of ceramide in ulcer formation and its relation to the activation of transcription factors and apoptosis. PMA was subserosally injected to rat glandular stomach. Fumonisin B1 (FB1), an inhibitor of ceramide synthase, was administered together with the PMA. The time course of ceramide content was quantified using thin layer chromatography and the number of apoptotic cells was determined by immunohistochemistry. The activation of transcription factor nuclear factor-κB (NF-κB) or activator protein-1 (AP-1) was evaluated using an electrophoretic mobility shift assay. The administration of FB1 attenuated PMA-induced gastric ulcer formation in a dose-dependent manner. Before the ulcers became obvious, the ceramide content (C18 and C24 ceramide) increased significantly in the gastric wall. The activation of NF-κB and AP-1 and an increase in the number of apoptotic cells were also observed. Both of these were significantly inhibited by the coad-ministration of FB1. However, NF-κB inhibitors attenuated gastric ulcer formation without affecting the ceramide content or the number of apoptotic cells. Ceramide formation in the stomach significantly contributes to PMA-induced tissue damage, possibly via the activation of transcription factors and an increase in apoptosis in the gastric mucosa. However, after the increase in ceramide levels, the NF-κB and apoptosis pathways may be separately involved in ulcer formation.

UR - http://www.scopus.com/inward/record.url?scp=0037379889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037379889&partnerID=8YFLogxK

U2 - 10.1124/jpet.102.045195

DO - 10.1124/jpet.102.045195

M3 - Article

C2 - 12649374

AN - SCOPUS:0037379889

VL - 305

SP - 232

EP - 239

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -